⌘K

Login Start Free

Home/Filings/4/0001209191-20-002343

4//SEC Filing

Graves Michael 4

Accession 0001209191-20-002343

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 6:21 PM ET

Size

5.4 KB

Accession

0001209191-20-002343

Insider Transaction Report

Form 4

Period: 2020-01-05

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Award
Stock Option (right to buy)
2020-01-05+10,000→ 10,000 total
Exercise: $59.80Exp: 2030-01-04→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The option fully vests on January 5, 2021, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001339978

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 6:21 PM ET
Size: 5.4 KB

View on SEC.gov